Ginkgo Bioworks Holdings DNA
NYSE DNA
$11.49 -0.27 (-2.30%)
As of: Oct 14, 2026 · 3:13 PM EDT

Ginkgo Bioworks Holdings (DNA) Gains from Sales and Divestitures (2022 - 2024)

Updated

Ginkgo Bioworks Holdings (DNA) recorded Gains from Sales and Divestitures of $1.22 million in Q4 2024.

Analysis

Ginkgo Bioworks Holdings (DNA) Gains from Sales and Divestitures (2022 - 2024) Analysis & Trends

For FY2024, Ginkgo Bioworks Holdings reported Gains from Sales and Divestitures of -$5.8 million.

  • Across earlier years, Gains from Sales and Divestitures came in at -$121.4 million in FY2023 and -$3.09 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Iqvia Holdings 43.58 Bn 35.29 Bn 1.44 Bn
2 Medpace Holdings 17.39 Bn 15.45 Bn 201.64 Mn
3 Charles River Laboratories International 14.53 Bn 13.73 Bn 363.37 Mn
4 Icon 13.23 Bn 10.34 Bn 479.29 Mn
5 Fortrea Holdings 2.01 Bn 1.39 Bn 139.20 Mn
6 Ginkgo Bioworks Holdings 712.22 Mn -49.86 Mn 18.44 Mn
7 Evotec SE 502.55 Mn -1.11 Bn -
8 Champions Oncology 66.57 Mn 41.65 Mn 7.70 Mn
9 MindWalk Holdings 64.01 Mn 27.66 Mn 1.61 Mn
10 Natural Alternatives International 6.63 Mn -21.45 Mn 1.73 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 1.22 Mn
Sep 30, 2024 -7.01 Mn
Sep 30, 2023 -112.40 Mn
Dec 31, 2022 -3.09 Mn
API Access

Ginkgo Bioworks Holdings Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=DNA&period=max&api_key=YOUR_API_KEY